ArticleScience advances2022

Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection.

Letícia de Almeida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.